|
|
||||||||
AJP - Endocrinology and Metabolism, Vol 272, Issue 5 E856-E863, Copyright © 1997 by American Physiological Society
ARTICLES |
F. Haddad, P. W. Bodell, S. A. McCue and K. M. Baldwin
Department of Physiology and Biophysics, University of California, Irvine 92717, USA.
Previous studies show that diabetes induces marked transformations in cardiac myosin heavy chain (MHC) gene expression that are somehow linked to the cellular action of thyroid hormone 3,5,3'-triiodothyronine (T3). In this study, we tested the hypothesis that diabetes induces a reduced expression of thyroid hormone receptors (TRs), which are known to be important transcription factors interacting with thyroid response elements (TREs) in the promoter region of both alpha- and beta-MHC genes. Adult female rats were randomly assigned to either a normal control (NC) or diabetic (D) group. Three and/or six weeks after induction of diabetes via streptozotocin injection, the hearts of the animals were analyzed for MHC and TR mRNA isoforms expression, nuclear T3 binding, and nuclear extract interaction with a palindromic TRE. Results showed that diabetes induced significant alteration in alpha- and beta-MHC expression. Northern blot analyses indicated no diabetes-associated differences in TR isoform mRNA signals. Cardiac nuclear T3 binding studies suggested no differences in either the binding capacity or the equilibrium binding constant among the two groups, indicating no changes in either the number of nuclear TRs or their affinity for T3. Furthermore, gel mobility shift assays detected no difference between NC and D groups for cardiac nuclear extract binding to palindromic TRE. Collectively, these findings suggest that, whereas diabetes exerts a profound effect on cardiac isomyosin gene expression, the underlying mechanism, although dependent on factors linked to T3 function, does not involve alterations in TR expression.
This article has been cited by other articles:
![]() |
J. Giger, A. X. Qin, P. W. Bodell, K. M. Baldwin, and F. Haddad Activity of the beta-myosin heavy chain antisense promoter responds to diabetes and hypothyroidism Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3065 - H3071. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Wright, P. W. Bodell, F. Haddad, A. X. Qin, and K. M. Baldwin In vivo regulation of the {beta}-myosin heavy chain gene in hypertensive rodent heart Am J Physiol Cell Physiol, May 1, 2001; 280(5): C1262 - C1276. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kinugawa, W. A. Minobe, W. M. Wood, E. C. Ridgway, J. D. Baxter, R. C. J. Ribeiro, M. F. Tawadrous, B. A. Lowes, C. S. Long, and M. R. Bristow Signaling Pathways Responsible for Fetal Gene Induction in the Failing Human Heart : Evidence for Altered Thyroid Hormone Receptor Gene Expression Circulation, February 27, 2001; 103(8): 1089 - 1094. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Baldwin and F. Haddad Plasticity in Skeletal, Cardiac, and Smooth Muscle: Invited Review: Effects of different activity and inactivity paradigms on myosin heavy chain gene expression in striated muscle J Appl Physiol, January 1, 2001; 90(1): 345 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Haddad, A. X. Qin, S. A. McCue, and K. M. Baldwin Thyroid receptor plasticity in striated muscle types: effects of altered thyroid state Am J Physiol Endocrinol Metab, June 1, 1998; 274(6): E1018 - E1026. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |